Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children
Clinical trial NCT01096056 · COMPLETED
Trial details
- NCT number
- NCT01096056
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-05
- Primary completion
- 2010-12-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.